First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2192
Publisher
MDPI AG
Online
2020-08-06
DOI
10.3390/cancers12082192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
- (2020) Sirpa Leppä et al. Blood Advances
- Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
- (2019) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- A systematic review of the efficacy of CNS prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era
- (2019) Toby A. Eyre et al. HAEMATOLOGICA
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
- (2018) Ayed O. Ayed et al. Blood Cancer Journal
- Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure
- (2018) Shaoxuan Hu et al. CANCER SCIENCE
- Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
- (2018) Daisuke Ennishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy
- (2018) Chulin Sha et al. JOURNAL OF CLINICAL ONCOLOGY
- Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
- (2017) Christian Grommes et al. Cancer Discovery
- Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)
- (2017) Dok Hyun Yoon et al. Oncotarget
- Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
- (2016) K. J. Savage et al. BLOOD
- CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2016) Norbert Schmitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era
- (2015) Anita Kumar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
- (2014) Peter J. Hosein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2014) Andrés J. M. Ferreri et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma
- (2014) C. Houillier et al. NEUROLOGY
- Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options
- (2013) A. Aviv et al. ANNALS OF ONCOLOGY
- Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
- (2012) H. Holte et al. ANNALS OF ONCOLOGY
- Treatment of Diffuse Large B Cell Lymphoma
- (2012) Jae-Yong Kwak KOREAN JOURNAL OF INTERNAL MEDICINE
- The Role of Genotype in 104 Cases of Diffuse Large B-Cell Lymphoma Primary of Breast
- (2011) Agustin Aviles et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
- (2011) W. M. Tai et al. ANNALS OF HEMATOLOGY
- Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution
- (2011) Suguru Fukuhara et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy
- (2011) Ho-Young Yhim et al. INTERNATIONAL JOURNAL OF CANCER
- First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
- (2011) Umberto Vitolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
- (2010) Ho-Young Yhim et al. BMC CANCER
- CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
- (2009) V. Boehme et al. BLOOD
- Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
- (2007) G. Ryan et al. ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started